Orismilast

DRUG3 trials

Sponsors

Hvidovre Hospital, Gentofte Hospital, Gregor Jemec

Conditions

Hidradenitis Suppurativaobesityulcerative colitis

Phase 2

Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa

Gregor JemecHidradenitis Suppurativa

Start: 2021-10-01End: 2022-12-01Target: 24Updated: 2021-09-28

Orismilast for the treatment of moderate to severe ulcerative colitis

CompletedCTIS2022-502763-37-02

Hvidovre Hospitalulcerative colitis

Start: 2023-11-16End: 2025-02-11Target: 20Updated: 2023-12-14

Weight management with orismilast alone or in combination with s.c. semaglutide (WELOSITI)

Not yet recruitingCTIS2024-517463-23-00

Gentofte Hospitalobesity

Target: 80Updated: 2025-01-21